Case studies

"A lot of the work that I do is historic-the maximum sentences change at different points of time. It's really complicated and people get it wrong all the time. That's when having a timeline is really useful."

1 High Pavement

Access all 242 documents on Statutory scheme

GET ACCESS NOW

GLOSSARY

Statutory scheme definition

Published by a LexisNexis Private Client expert

What does Statutory scheme mean?

A retirement benefit scheme established by statute usually for public sector employees.

Speed up all aspects of your legal work with tools that help you to work faster and smarter. Win cases, close deals and grow your business–all whilst saving time and reducing risk.

Issue of redeemable shares

Issue of redeemable shares A limited company having a share capital may issue redeemable shares. Redeemable shares are a statutory concept contained in the Companies Act 2006 (CA 2006), which includes detailed provisions relating to the terms, manner, financing and timing of their redemption. A redemption of shares by a limited company having a share capital will be void unless it is carried out in accordance with CA 2006, Pt 18 (CA 2006, ss 658–737), which sets out the statutory framework within which a limited company is permitted to acquire its own shares. In addition, if such a company purports to redeem shares without complying with CA 2006, Pt 18, an offence is committed by the company and every one of its officers in default. A person guilty of such an offence is liable: • on conviction on indictment, to imprisonment for a term not exceeding two years or a fine (or both), or • on summary conviction in England and Wales, to imprisonment for a term not...

Court procedure—reduction of capital—effect of the reduction

Court procedure—reduction of capital—effect of the reduction It is a fundamental rule of English company law that a limited company having a share capital must maintain that capital. Therefore, a company must not reduce its capital, except as prescribed by law. This capital maintenance rule is intended to protect a company’s creditors by ensuring that the assets representing the capital of a company remain available to them for future recourse. There are provisions in the Companies Act 2006 (CA 2006) governing how a limited company may reduce its capital. The restrictions in CA 2006 relating to reductions of capital do not apply to unlimited companies. For further information on this type of company, see Practice Note: Unlimited companies. The focus of this Practice Note is on reductions of capital in accordance with CA 2006, Pt 17, Ch 10, in particular, those carried out by a special resolution confirmed by court order (the court procedure) rather than those carried out by a special resolution supported by a solvency...

Discover our 109 Practice Notes on Statutory scheme

Letter—Employee’s appeal against rejection of flexible working request

Letter—Employee’s appeal against rejection of flexible working request [Insert name and job title of intended recipient] [Insert name of employer company] [Insert address of recipient at employer] [Insert date] Dear [insert name] I refer to my flexible working request dated [insert date which appeared on employee’s request] and the [insert name of employer company]’s decision dated [insert date], which I received on [insert date]. I am writing to appeal against

Policy—time off for dependants

Policy—time off for dependants 1 Introduction 1.1 This policy sets out the approach that [enter name of organisation] (the Company) will take in relation to the statutory right that employees have to take unpaid time off work to deal with unexpected events affecting their dependants and the steps you should take if you need to make a request for such leave. 1.2 [This policy applies only to employees. It does not apply to agency workers, consultants[, contractors] [, volunteers] [, interns] or casual workers. OR This policy applies to all employees, officers, agency workers, consultants[, contractors] [, volunteers] [, interns] and casual workers.] 1.3 [This policy has been [agreed OR implemented following consultation] with [[enter name of relevant trade union(s)] OR [enter name of works council] OR [enter name of staff association]].] 1.4 An employee may have the right to neonatal care leave and pay if their child receives neonatal care. For further information, see the Company’s [neonatal leave policy]. This policy should be read in...

Dive into our 13 Precedents related to Statutory scheme

Does a bonus issue have to be carried out so that the shares are offered to all existing shareholders in a company or can a company choose which shareholders to allot bonus shares to?

Does a bonus issue have to be carried out so that the shares are offered to all existing shareholders in a company or can a company choose which shareholders to allot bonus shares to? In this Q&A, we have assumed that the company proposing to carry out a bonus issue is a private company limited by shares. A bonus issue is the allotment of shares by a company to its existing shareholders, usually on the basis that they are fully-paid (as that is often a requirement of its articles of association), and without any payment being required by shareholders for those shares. In essence, a bonus issue will involve a resolution of a company to effect the capitalisation of existing reserves into (normally) fully-paid shares by allotting the shares and applying reserves in paying them up. It is not possible for a shareholder in a company that is making a bonus issue to refuse the allotment of any shares that they are entitled to or to...

Once the Flexible Working (Amendment) Regulations 2023 come into force on 6 April 2024, will an individual have the right to make a flexible working request once they have signed an employment contract, even though they have not yet started work?

Once the Flexible Working (Amendment) Regulations 2023 come into force on 6 April 2024, will an individual have the right to make a flexible working request once they have signed an employment contract, even though they have not yet started work? For information on flexible working generally, see Practice Note: Flexible working. The Flexible Working (Amendment) Regulations 2023, SI 2023/1328, which comes into force on 6 April 2024, removes Flexible Working Regulations 2014, SI 2014/1398, reg 3, which provides that only an employee who has been continuously employed for at last 26 weeks is entitled to make a flexible working application. Once Flexible Working Regulations 2014, SI 2014/1398, reg 3 is removed, there will be no regulations specifying who is a ‘qualifying employee’ for the purpose of section 80F of the Employment Rights Act 1996 (ERA 1996). Any ‘employee’ will then be able to make a flexible working request. The change has been described as giving workers the right to request flexible working ‘from day one of a new job...

See the 93 Q&As about Statutory scheme

UK government increases payment rate for branded medicines under the statutory scheme

The Department of Health and Social Care has confirmed that, following consultation, the statutory payment rate pharmaceutical companies must pay on NHS sales of newer branded medicines will rise from 15.5% to 31.3% from 1 July 2025. The adjustment raises the statutory scheme’s average annual payment rate to 23.4% in 2025, with headline rates of 24.3% and 26.0% set for 2026 and 2027 respectively. This move positions the UK’s repayment rates well above those in comparable markets, with Germany and France requiring repayments of 7% and 5.7% respectively.

Life Sciences weekly highlights—12 June 2025

This week's edition of Life Sciences weekly highlights includes news that the European Commission opened a public consultation on high-risk AI classification and obligations under the EU AI Act, the DHSC responded to the consultation on the proposed review of the statutory scheme for branded medicines pricing and the Branded Health Service Medicines (Costs) (Amendment) Regulations 2025 amended the statutory payment rates, the EFPIA and Medicines for Europe expressed diverging views on the Council of the EU’s position on the EU pharma reform package, the MHRA published several new guidance documents on decentralised manufacture as well as the UK’s first official guidance on the regulatory framework for the development of bacteriophage therapies, and the Patents Court granted an interim injunction to restrain multiple respondents from marketing generic dapagliflozin products pending the resolution of an appeal by AstraZeneca. Further news included is that the EMA opened a consultation on draft ICH guideline to promote the inclusion and retention of pregnant and breastfeeding individuals in clinical trials, the Innovative Health Initiative launched...

Read the latest 27 News articles on Statutory scheme